Thomas Jefferson University Research Facility is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.
Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.
Thomas Jefferson University Research Facility has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Non-Small Cell Lung Cancer, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation.
Sponsors: Pierre Fabre Medicament.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Philadelphia
Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Thomas Jefferson University Research Facility has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Thomas Jefferson University Research Facility has 1 clinical trials on record, with 1 currently active. Their work covers Non-Small Cell Lung Cancer, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation.
Thomas Jefferson University Research Facility has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.